Loading...

Bio Business

Most Recent

image: Biology Hacklabs

Biology Hacklabs

By Megan Scudellari | March 1, 2013

Fueled by donations, sweat, and occasional dumpster diving, community laboratories for DIY biologists are cropping up around the country.

2 Comments

image: A Dime a Dozen

A Dime a Dozen

By Megan Scudellari | January 1, 2013

Affordable diagnostic tests tackle the world’s most pressing health problems.

0 Comments

image: Tumor Snipers

Tumor Snipers

By Megan Scudellari | November 1, 2012

After two headline successes, companies rush to develop “smart bomb” cancer drugs.

0 Comments

image: Sharing Made Easy

Sharing Made Easy

By Megan Scudellari | September 1, 2012

Biological resource centers are bigger and better than ever before, storing and distributing shared reagents, plasmids, and more.

1 Comment

image: The Little Cell That Could

The Little Cell That Could

By Megan Scudellari | July 1, 2012

Critics point out that cell therapy has yet to top existing treatments. Biotech companies are setting out to change that—and prove that the technology can revolutionize medicine.

1 Comment

image: Treating Fat with Fat

Treating Fat with Fat

By Edyta Zielinska | May 1, 2012

Is brown fat ready for therapeutic prime time?

22 Comments

image: Braving the IPO Drought

Braving the IPO Drought

By Megan Scudellari | March 1, 2012

Despite nervous investors and a volatile market, a courageous few biotechnology companies are taking their chances on Wall Street.

0 Comments

image: Bioterrorist Battles

Bioterrorist Battles

By Fran Hawthorne | January 1, 2012

A Swiss-based firm may have a back-door way to thwart a bioterrorist attack—by fighting the flu.

9 Comments

image: New Tech Boosts Science

New Tech Boosts Science

By Tia Ghose | October 1, 2011

From iPhone apps to cloud computing, everyday digital technologies are helping advance drug discovery, conduct clinical trials, and improve medical care.

0 Comments

image: Make Mine Rare

Make Mine Rare

By Megan Scudellari | August 1, 2011

With mounting interest from biotechs, Big Pharma, and the federal government, research on rare diseases is burgeoning.

6 Comments

Popular Now

  1. Estonia Offers Free Genetic Testing to Residents
  2. Human Brain Organoids Thrive in Mouse Brains
  3. RNA Injection Restores Hearing in Guinea Pigs
  4. Jim Bridenstine Confirmed to Lead NASA